Mouse Anti-FKBP10 (AA 7-176) Recombinant Antibody (CBXF-3044) (CBMAB-F3746-CQ)
Basic Information
Formulations & Storage [For reference only, actual COA shall prevail!]
Target
Collagen fibril organization Source: Ensembl
Extracellular matrix assembly Source: Ensembl
In utero embryonic development Source: Ensembl
Peptidyl-lysine hydroxylation Source: Ensembl
Peptidyl-proline modification Source: FlyBase
Wound healing Source: Ensembl
A form of osteogenesis imperfecta, a connective tissue disorder characterized by low bone mass, bone fragility and susceptibility to fractures after minimal trauma. Disease severity ranges from very mild forms without fractures to intrauterine fractures and perinatal lethality. Extraskeletal manifestations, which affect a variable number of patients, are dentinogenesis imperfecta, hearing loss, and blue sclerae. OI11 is an autosomal recessive form.
Bruck syndrome 1 (BRKS1):
A disease characterized by generalized osteopenia, congenital joint contractures, fragile bones with onset of fractures in infancy or early childhood, short stature, severe limb deformity, progressive scoliosis, and pterygia.
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon
Submit a review
Loading...
Please try the standard protocols which include: protocols, troubleshooting and guide.
Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols
Related Products
Mouse Anti-FKBP10 Recombinant Antibody (CBXF-1970) (CAT#: CBMAB-F1105-CQ)
Mouse Anti-FKBP10 Recombinant Antibody (3B5) (CAT#: CBMAB-A2994-LY)
Mouse Anti-FKBP10 Recombinant Antibody (CBXF-3042) (CAT#: CBMAB-F3744-CQ)
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us

